The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter

Clinical Genetics

Volumn 81, Issue 5, 2012, Pages 421-429

  Voorwinden, J S ^a   Jaspers, J P C ^a   Ter Beest, J G ^a   Kievit, Y ^a   Sijmons, R H ^a   Oosterwijk, J C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

BRCA; Genetic counselling; Lynch syndrome; Patient satisfaction; Predictive testing; Result disclosure

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; CLINICAL DECISION MAKING; CLINICAL GENETICS; CLINICAL RESEARCH; CONSULTATION; DNA DETERMINATION; FEMALE; GENE MUTATION; GENETIC COUNSELING; HEALTH CARE QUALITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE;

ADULT; CHOICE BEHAVIOR; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DISCLOSURE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; PATIENT ACCESS TO RECORDS; PATIENT SATISFACTION; QUALITATIVE RESEARCH; QUESTIONNAIRES;

EID: 84859620944     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01811.x     Document Type: Article

References (24)

1. Dutch Society of Clinical Genetics. Guideline predictive DNA-testing. Quality commission of the VKGN. 2007. Retrieved October 28, 2010, from
2. Tibben A. Predictive testing for Huntington's disease. Brain Res Bull 2007: 72: 165-171.
3. Van Oostrom I, Tibben A. A counselling model for BRCA1/2 genetic susceptibility testing. Hered Cancer Clin Pract 2004: 2: 19-23.
4. Smith AW, Dougall AL, Posluszny DM, Somers TJ, Rubinstein WS, Baum A. Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psychooncology 2008: 17: 767-773.
5. Beran TM, Stanton AL, Kwan L et al. The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Ann Behav Med 2008: 36: 107-116.
6. Shiloh S, Koehly L, Jenkins J, Hadley D. Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study. Psychooncology 2008: 17: 746-755.
7. Collins VR, Meiser B, Ukoumunne OC, Gaff C, St John DJ, Halliday JL. The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genet Med 2008: 9: 290-297.
8. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 2005: 14: 1060-1074.
9. Wagner A, van Kessel I, Kriege MG et al. Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 2005: 4: 295-300.
10. Arver B, Haegermark A, Platten U, Lindblom A, Brandberg Y. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ ovarian and colon cancer pre-disposing genes: a 12 month follow-up. Fam Cancer 2004: 3: 109-116.
11. van Oostrom I, Meijers-Heijboer H, Lodder LN et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5 year follow-up study. Am J Clin Oncol 2003: 21: 3867-3874.
12. Baumanis L, Evans JP, Callanan N, Susswein LR. Telephoned BRCA1/2 genetic test results: prevalence, practice and patient satisfaction. J Genet Couns 2009: 18: 447-463.
13. Jenkins J, Calzone KA, Dimond E et al. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counselling. Genet Med 2007: 9: 487-495.
14. Klemp JR, O'Dea A, Chamerlain C, Fabian CJ. Patient satisfaction of BRCA1/2 genetic testing by women at high risk for breast cancer participating in a prevention trial. Fam Cancer 2005: 4: 279-284.
15. Berkenstadt M, Shiloh S, Barkai G, Katznelson MB, Goldman B. Perceived Personal Control (PPC): a new concept in measuring outcome of genetic counselling. Am J Med Genet 1999: 82: 53-59.
16. Smets EM, Pieterse AH, Aalfs CM, Ausems MG, van Dulmen AM. The Perceived Personal Control (PPC) questionnaire as an outcome of genetic counselling: reliability and validity of the instrument. Am J Med Genet 2006: 140: 843-850.
17. Ockhuysen-Vermey CF, Henneman L, van Asperen CJ, Oosterwijk JC, Menko FH, Timmermans DR. Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risk in genetic counselling. BMC Cancer 2008: 8: 283-285.
18. Goldberg DP, Williams P. A users guide to the General Health Questionnaire. Windsor, UK: NFER Nelson, 1988.
19. Lerman C, Trock B, Rimer B, Jepson C, Brody D, Boyce A. Psychological side effects of breast cancer screening. Health Psychol 1991: 10: 259-267.
20. Helmes AW, Culver JO, Bowen DJ. Results of a randomized study of telephone versus in-person breast cancer risk counselling. Patient Educ Couns 2006: 64: 96-103.
21. ca: development of a counselee-centered instrument to measure needs and preferences in genetic counselling for hereditary cancer. Psychooncology 2005: 14: 361-375.
22. Vos J, Gomez-Garcia E, Oosterwijk JC et al. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result. Psychooncology 2011: (in press).
23. Meiser B, Gleeson MA, Tucker KM. Psychological impact of genetic testing for adult-onset disorders. An update for clinicians. Med J Aust 2000: 172: 126-129.
24. Wagner TM, Möslinger R, Langbauer G et al. Attitude towards prohylactic surgery and effects of genetic counselling in families with BRCA mutations. Br J Cancer 2000: 82: 1249-1253.